Skip to Content
Uncategorized

Therapeutic Cloning

President Bush probably will not reverse his position on stem cell research, even if it is mostly symbolic (embryos, after all, are destroyed every day in reproductive clinics–perhaps some White House press corps member would ask the president about this…
November 8, 2004

President Bush probably will not reverse his position on stem cell research, even if it is mostly symbolic (embryos, after all, are destroyed every day in reproductive clinics–perhaps some White House press corps member would ask the president about this someday). The battle over therapeutic cloning, however, goes on in the Senate. And it appears that a ban on such cloning, lacking the support of Senators such as Orrin Hatch and Arlen Specter, probably would not muster a simple majority in the Senate–much less the 60 votes needed to break a filibuster. “The question is whether the Democrats and stem-cell supporters among Republicans can still hang tough,” says one observer, especially when contentious Supreme Court appointments loom in the near future. Some hope that passage of Proposition 71 in California will put pressure on President Bush to change his stem cell policy, a proposition that unfortunately looks unlikely from this president.

Keep Reading

Most Popular

Geoffrey Hinton tells us why he’s now scared of the tech he helped build

“I have suddenly switched my views on whether these things are going to be more intelligent than us.”

Meet the people who use Notion to plan their whole lives

The workplace tool’s appeal extends far beyond organizing work projects. Many users find it’s just as useful for managing their free time.

Learning to code isn’t enough

Historically, learn-to-code efforts have provided opportunities for the few, but new efforts are aiming to be inclusive.

Deep learning pioneer Geoffrey Hinton has quit Google

Hinton will be speaking at EmTech Digital on Wednesday.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.